TSCAN THERAPEUTICS INC. - COMMON STOCK

TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

12 نوفمبر 2024 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition

05 نوفمبر 2024 09:15:27 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting

04 أكتوبر 2024 09:05:45 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Participate in Upcoming Investor Conferences

29 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

12 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Updates to its Board of Directors

14 يونيو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

30 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies

29 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

13 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

09 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

24 أبريل 2024 16:05:34 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

24 أبريل 2024 11:03:30 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

22 أبريل 2024 17:01:23 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Closing of Upsized Public Offering

19 أبريل 2024 10:05:23 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

17 أبريل 2024 00:30:57 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

16 أبريل 2024 16:25:22 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

16 أبريل 2024 16:01:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

08 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

02 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

06 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire